University of Southern California: Neoplasms trials

The registry lists 26 Neoplasms studies with University of Southern California as lead sponsor. 5 are open to participants now and 4 have results posted.

Early Phase 1 1Phase 1 6Phase 2 3No phase 17(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• eMOTION: Examining Implicit Attitudes in Physical Activity EngagementRecruitingNCT07044570
• eMOTION: Examining Affective Mechanisms in Physical Activity EngagementRecruitingNCT06570642Not applicable
• A Dose Finding Phase 1 of Sarilumab Plus Capecitabine in HER2/Neu-Negative Metastatic Breast Cancer and a Single-arm, Historically-controlled Phase 2 Study of Sarilumab Plus Capecitabine in Stage I-III Triple Negative Breast Cancer With High-Risk Residual Disease (EMPOWER)RecruitingNCT04333706Phase 1/2
• Collection of Immunology Specimens From Patients With Cancer or Blood Disorders, and Healthy VolunteersRecruitingNCT03207854
• Norris ORIEN Total Cancer CareRecruitingNCT02970045
• eMOTION Formative StudyCompletedNCT06125964Not applicableResults posted
• IRX-2 Regimen in Treating Women With Cervical Squamous Intraepithelial Neoplasia 3 or Squamous Vulvar Intraepithelial Neoplasia 3TerminatedNCT03267680Phase 2Results posted
• Expanding Access to Home-Based Palliative CareTerminatedNCT03128060Not applicableResults posted
• Regorafenib in Treating Patients With Advanced or Metastatic Neuroendocrine TumorsCompletedNCT02259725Phase 2Results posted
• 18F-FMAU PET/CT and MRI for the Detection of Brain Tumors in Patients With Brain Cancer or Brain MetastasesCompletedNCT04752267Early Phase 1
• Movement and Fitness Trackers in Determining Performance StatusTerminatedNCT03971266Not applicable
• Virtual Reality in Reducing Pain and Anxiety in Cancer Participants Undergoing Painful ProceduresSuspendedNCT03568292Not applicable
• Oncology Research Information Exchange Network in Improving Genetic Screening Rate in Patients With CancerWithdrawnNCT03348137
• QSM and Regional DCE MRI Permeability Using GOCART TechniqueWithdrawnNCT03091803
• Clinical Model in Evaluating Clinical, Psychosocial, and Health Economic Factors in Adolescent and Young Adult Patients With CancerTerminatedNCT03057639
• Perceptions of Side Effects of Cancer ChemoradiotherapyCompletedNCT02978846
• Ringing a Bell on the Final Day of Radiation Therapy in Improving the Memory of Distress in Cancer PatientsCompletedNCT02970617Not applicable
• Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain MetastasesTerminatedNCT02967380Not applicable
• Whole-Neck Computed Tomography Perfusion Scan in Imaging Patients With Head and Neck TumorsCompletedNCT02960308
• 18F-FMAU PET/CT in Imaging Patients With Advanced CancersTerminatedNCT02079181Not applicable
• Genetics in Predicting Risk of Bisphosphonate-Related Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic AcidWithdrawnNCT02069340Not applicable
• Nanosomal Docetaxel Lipid Suspension in Treating Patients With Advanced Solid TumorsCompletedNCT01957995Phase 1
• Recombinant Albumin Fusion Protein sEphB4-HSA in Treating Patients With Metastatic or Recurrent Solid TumorsTerminatedNCT01642342Phase 1
• Ixabepilone and Pemetrexed/Solid TumorsWithdrawnNCT01170871Phase 1
• Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid TumorsCompletedNCT01155258Phase 1
• Oral NRX 194204 in Patients With Refractory MalignanciesTerminatedNCT00630760Phase 1